Challenges of implementing human papillomavirus (HPV) vaccination policy.
Raffle
Angela E
AE
Bristol Primary Care Trust, King Square, Bristol BS2 8EE. angela.raffle@bristolpct.nhs.uk
D001294:Attitude to Health; D003365:Costs and Cost Analysis; D005260:Female; D006291:Health Policy; D006801:Humans; D017589:Immunization Programs; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000191:economics / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000191:economics; D010342:Patient Acceptance of Health Care; D002583:Uterine Cervical Neoplasms / Q000191:economics / Q000517:prevention & control* / Q000821:virology; D014611:Vaccination / Q000191:economics / Q000379:methods*
D053918:Papillomavirus Vaccines
Eur J Cancer. 2000 Nov;36(17):2260-5
11072217
Euro Surveill. 2007 Apr;12(4):E070426.1
17868608
BMJ. 2003 Apr 26;326(7395):901
12714468
Lancet. 1985 Aug 17;2(8451):363-4
2862517
Lancet. 1995 Dec 9;346(8989):1566-7
7491080
BMJ. 1999 Apr 3;318(7188):904-8
10102852
Lancet. 2004 Nov 13-19;364(9447):1731-2
15541429
Issues Emerg Health Technol. 2005 Dec;(75):1-4
16544439
Vaccine. 2006 Apr 12;24(16):3087-94
16500736
Br J Cancer. 2006 Jul 3;95(1):56-61
16773068
Int J STD AIDS. 2006 Aug;17(8):517-21
16925896
Vaccine. 2006 Aug 31;24 Suppl 3:S3/114-21
16949998
Hum Vaccin. 2006 Nov-Dec;2(6):243-8
17102643
MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24
17380109
N Engl J Med. 2007 May 10;356(19):1915-27
17494925
N Engl J Med. 2007 May 10;356(19):1990-1
17494932
Lancet. 2007 Jun 30;369(9580):2135-7
17602733
Lancet. 2007 Jun 30;369(9580):2161-70
17602732